ASCLETIS-B (01672) spent 2.4837 million Hong Kong dollars to repurchase 200,000 shares on December 23rd.
Sing Lee Pharmaceuticals Group Limited (01672) announced on December 23, 2025 the repurchase of 200,000 shares at a cost of HK$2.4837 million.
ASCLETIS-B (01672) announced that it will spend HKD 2.4837 million to repurchase 200,000 shares on December 23, 2025.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
